GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » DermTech Inc (MEX:DMTK) » Definitions » Earnings Yield (Joel Greenblatt) %

DermTech (MEX:DMTK) Earnings Yield (Joel Greenblatt) % : -232.56% (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is DermTech Earnings Yield (Joel Greenblatt) %?

DermTech's Enterprise Value for the quarter that ended in Mar. 2024 was MXN2,189.5 Mil. DermTech's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was MXN-1,571.6 Mil. DermTech's Earnings Yield (Joel Greenblatt) for the quarter that ended in Mar. 2024 was -232.56%.

The historical rank and industry rank for DermTech's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:

MEX:DMTK' s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: -9012.46   Med: -26.27   Max: 1999.83
Current: -588.24

During the past 8 years, the highest Earnings Yield (Joel Greenblatt) of DermTech was 1999.83%. The lowest was -9012.46%. And the median was -26.27%.

MEX:DMTK's Earnings Yield (Joel Greenblatt) % is ranked worse than
98.65% of 223 companies
in the Medical Diagnostics & Research industry
Industry Median: -2.89 vs MEX:DMTK: -588.24

Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.

A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. DermTech's Forward Rate of Return (Yacktman) % for the quarter that ended in Mar. 2024 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past seven years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.


DermTech Earnings Yield (Joel Greenblatt) % Historical Data

The historical data trend for DermTech's Earnings Yield (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DermTech Earnings Yield (Joel Greenblatt) % Chart

DermTech Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Dec20 Dec21 Dec22 Dec23
Earnings Yield (Joel Greenblatt) %
Get a 7-Day Free Trial -3.59 -5.79 -30.58 714.29 -175.44

DermTech Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Earnings Yield (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -185.19 -217.39 -312.50 -175.44 -232.56

Competitive Comparison of DermTech's Earnings Yield (Joel Greenblatt) %

For the Diagnostics & Research subindustry, DermTech's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DermTech's Earnings Yield (Joel Greenblatt) % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, DermTech's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where DermTech's Earnings Yield (Joel Greenblatt) % falls into.



DermTech Earnings Yield (Joel Greenblatt) % Calculation

In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.

DermTechs Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Dec. 2023 is calculated as

Earnings Yield (Joel Greenblatt)=EBIT/Enterprise Value
=-1760.892/1896.347555
=-92.86 %

DermTech's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-1,571.6 Mil.



DermTech  (MEX:DMTK) Earnings Yield (Joel Greenblatt) % Explanation

Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.

Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.


Be Aware

Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.

Forward Rate of Return (Yacktman) % based on Don Yacktman's definition is a better measure of the expected rate of return for a stock.


DermTech Earnings Yield (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of DermTech's Earnings Yield (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.


DermTech Business Description

Traded in Other Exchanges
Address
12340 El Camino Real, San Diego, CA, USA, 92130
DermTech Inc is an emerging growth molecular diagnostic company. The company is engaged in marketing and developing novel non-invasive genomic tests to aid in the diagnosis of various skin conditions, including skin cancer, inflammatory diseases, and aging-related conditions. While the company generates revenue through laboratory services.

DermTech Headlines

No Headlines